Ildong Pharmaceutical Co Ltd (000230):企業の財務・戦略的SWOT分析

◆英語タイトル:Ildong Pharmaceutical Co Ltd (000230) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15121
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ildong Pharmaceutical Co Ltd (IPC) is a manufacturer of pharmaceutical products. The company offers finished drugs, health foods and foods, raw material drugs, cosmetics and medical devices and others. Its raw material drugs comprise synthesis, probiotics, vitamins and biometabolites. IPC also offers finished drugs such as anti-histamine drugs, antineoplastic agents, antifungals and antivirals, blood circulation, endocrine and metabolic system, cardiovascular system, central nervous system, gastrointestinal system, respiratory system, topical preparation, urogenital system and other products. The company operates plants in Gyeonggi-do, Chungcheongbuk-do, and others. It markets its products in South Korea and abroad. IPC is headquartered in Seoul, South Korea.

Ildong Pharmaceutical Co Ltd Key Recent Developments

Jul 09,2018: Local drug makers strive to conquer neurological diseases

This comprehensive SWOT profile of Ildong Pharmaceutical Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Ildong Pharmaceutical Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Ildong Pharmaceutical Co Ltd – Key Information
Ildong Pharmaceutical Co Ltd – Overview
Ildong Pharmaceutical Co Ltd – Key Employees
Ildong Pharmaceutical Co Ltd – Key Employee Biographies
Ildong Pharmaceutical Co Ltd – Key Operational Heads
Ildong Pharmaceutical Co Ltd – Major Products and Services
Ildong Pharmaceutical Co Ltd – History
Ildong Pharmaceutical Co Ltd – Company Statement
Ildong Pharmaceutical Co Ltd – Locations And Subsidiaries
Ildong Pharmaceutical Co Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Ildong Pharmaceutical Co Ltd – Business Description
Ildong Pharmaceutical Co Ltd – Corporate Strategy
Ildong Pharmaceutical Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Ildong Pharmaceutical Co Ltd – Strengths
Ildong Pharmaceutical Co Ltd – Weaknesses
Ildong Pharmaceutical Co Ltd – Opportunities
Ildong Pharmaceutical Co Ltd – Threats
Ildong Pharmaceutical Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Ildong Pharmaceutical Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Ildong Pharmaceutical Co Ltd, Key Information
Ildong Pharmaceutical Co Ltd, Key Ratios
Ildong Pharmaceutical Co Ltd, Share Data
Ildong Pharmaceutical Co Ltd, Major Products and Services
Ildong Pharmaceutical Co Ltd, History
Ildong Pharmaceutical Co Ltd, Key Employees
Ildong Pharmaceutical Co Ltd, Key Employee Biographies
Ildong Pharmaceutical Co Ltd, Key Operational Heads
Ildong Pharmaceutical Co Ltd, Other Locations
Ildong Pharmaceutical Co Ltd, Subsidiaries
Ildong Pharmaceutical Co Ltd, Key Manufacturing facilities
Ildong Pharmaceutical Co Ltd, Key Competitors
Ildong Pharmaceutical Co Ltd, SWOT Analysis
Ildong Pharmaceutical Co Ltd, Ratios based on current share price
Ildong Pharmaceutical Co Ltd, Annual Ratios
Ildong Pharmaceutical Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Ildong Pharmaceutical Co Ltd, Performance Chart
Ildong Pharmaceutical Co Ltd, Ratio Charts

★海外企業調査レポート[Ildong Pharmaceutical Co Ltd (000230):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TreeHouse Foods Inc:企業の戦略・SWOT・財務分析
    TreeHouse Foods Inc - Strategy, SWOT and Corporate Finance Report Summary TreeHouse Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Blue Earth Inc:電力:M&Aディール及び事業提携情報
    Summary Blue Earth Inc (Blue Earth), formerly Genesis Fluid Solutions Holdings Inc is a renewable energy solutions provider. The company's services include energy efficiency solutions, alternative energy solutions, renewable energy solutions, acquisition, alternative and renewable energy plants fina …
  • Orthosera GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Orthosera GmbH (OrthoSera), formerly Lacerta Technologies GmbH is a regenerative medicine company that develops blood serum for human diseases. The company offers Albumin, a bone protein used in treatment of patients suffering from bone loss. It develops technologies for identification of ne …
  • MPI Research Inc-製薬・医療分野:企業M&A・提携分析
    Summary MPI Research Inc (MPI) is a contract research company that provides preclinical and early clinical research services. The company’s services comprise drug safety services, discovery sciences solutions, bioanalytical and analytical solutions, surgical services, medical device evaluation, tran …
  • WntResearch AB (WNT):製薬・医療:M&Aディール及び事業提携情報
    Summary WntResearch AB (WntResearch) is a biotechnology company that develops novel anti-metastatic therapies for the treatment of cancer. The company's development stage products include Foxy-5 and Box-5. Its lead project, Foxy-5, a peptide which is in Phase I clinical development for reconstitutin …
  • IMI Plc (IMI):石油・ガス:M&Aディール及び事業提携情報
    Summary IMI Plc (IMI) is a manufacturer of valve and fluid technology solutions. The company designs, manufactures and services engineered products that control the precise movement of fluids. It offers critical flow control solutions that enable energy and process industries to operate safely and e …
  • Wells Fargo Private Bank:企業の戦略・SWOT・財務分析
    Wells Fargo Private Bank - Strategy, SWOT and Corporate Finance Report Summary Wells Fargo Private Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Steel Connect Inc (STCN):企業の財務・戦略的SWOT分析
    Steel Connect Inc (STCN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Chennai Petroleum Corporation Ltd (CHENNPETRO):企業の財務・戦略的SWOT分析
    Chennai Petroleum Corporation Ltd (CHENNPETRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Royal Dutch Shell Plc (RDSA):電力:M&Aディール及び事業提携情報
    Summary Royal Dutch Shell plc (Shell) is an integrated oil and gas company. The company explores for and produces oil and gas from conventional fields and sources such as tight rock, shale and coal formations. Its refining and petrochemical complexes across the world add value to its upstream produc …
  • Gokul Refoils & Solvent Ltd. (GOKULEQ):企業の財務・戦略的SWOT分析
    Gokul Refoils & Solvent Ltd. (GOKULEQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Universal Health Services, Inc.:企業の戦略・SWOT・財務情報
    Universal Health Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Universal Health Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • W&T Offshore Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    W&T Offshore Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary W&T Offshore Inc (W&T Offshore) is an independent oil and natural gas company. It carries out acquisition, exploitation, development and exploration of oil and natural gas assets both onshore and of …
  • Neurimmune Holding AG-製薬・医療分野:企業M&A・提携分析
    Summary Neurimmune Holding AG (Neurimmune), formerly known as Neurimmune Therapeutics AG is a biopharmaceutical company that develops immunotherapeutics. The company’s pipeline products include human-derived monoclonal antibodies developed for the treatment and prevention of human disorders with a f …
  • Plymouth Rock Assurance Corporation:企業の戦略・SWOT・財務情報
    Plymouth Rock Assurance Corporation - Strategy, SWOT and Corporate Finance Report Summary Plymouth Rock Assurance Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Kazanorgsintez (KZOS):企業の財務・戦略的SWOT分析
    Kazanorgsintez (KZOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Biogen Inc (BIIB)-医療機器分野:企業M&A・提携分析
    Summary Biogen Inc (Biogen) is a global biotechnology company that manufactures and markets drugs for the treatment of neurodegenerative diseases and rare and autoimmune disorders. Its marketed products include Avonex (interferon beta-1a), Tysabri (natalizumab), Tecfidera (dimethyl fumarate), Zinbry …
  • Ithaca Energy Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Ithaca Energy Inc. (Ithaca), a subsidiary of Delek Group Ltd., is an oil and gas company, which explores for, develops, and produces oil and gas in the North Sea. It focuses on the appraisal and development of undeveloped discoveries and the exploitation of its existing UK producing asset po …
  • Idaho Power Co:企業の戦略的SWOT分析
    Idaho Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Sony Financial Holdings Inc.:企業の戦略・SWOT・財務分析
    Sony Financial Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Sony Financial Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆